Shankar Hariharan

Insider Reports History

Location: Commack, NY
Signature: /s/ Kate L. Bechen, as attorney-in-fact for Shankar Hariharan
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shankar Hariharan:

Form 4 holding Co-CEO & Chairman, Director, 10%+ Owner

Scienture Holdings, Inc.

Security class: Common Stock, par value $0.00001
Shares / value: 3,518,679
Estimated value: $1,618,592
Report date: 20 Feb 2026
Price: $0.4600
Ownership: Direct

Form 4 holding Co-CEO & Chairman, Director, 10%+ Owner

Scienture Holdings, Inc.

Security class: Common Stock, par value $0.00001
Shares / value: 371,704
Estimated value: $170,983
Report date: 19 Sep 2024
Price: $0.4600
Ownership: By Spouse

Form 4 holding Co-CEO & Chairman, Director, 10%+ Owner

Scienture Holdings, Inc.

Security class: Series X Non-Voting Convertible Preferred Stock
Shares / value: 0
Estimated value
Report date: 19 Sep 2024
Price
Ownership: By spouse
Underlying class: Common Stock, par value $0.00001
Underlying amount

Form 4 holding Co-CEO & Chairman, Director, 10%+ Owner

Scienture Holdings, Inc.

Security class: Series X Non-Voting Convertible Preferred Stock
Shares / value: 0
Estimated value
Report date: 19 Sep 2024
Price
Ownership: Direct
Underlying class: Common Stock, par value $0.00001
Underlying amount

Insider Reports Filed by Shankar Hariharan

4 SCNX

Scienture Holdings, Inc.

Report period: 19 Sep 2024
Transactions: 8
Transaction value: $0
Filing time: 12 Mar 2026, 21:32
Role: Co-CEO & Chairman, Director, 10%+ Owner
Next action: Open filing details

3 SCNX

TRxADE HEALTH, INC

Report period: 25 Jul 2024
Transactions: 0
Transaction value: $0
Filing time: 05 Aug 2024, 21:23
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .